Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
August 8, 2013 -- Mitsubishi Tanabe Pharma announced it will spend $19.5 million to build a new China production facility in Tianjin. The plant will be owned by Tianjin Tanabe Seiyaku, a joint venture in which Mitsubishi holds a 75% stake. Its local partner, Tianjin Lisheng Pharmaceutical Co., owns the remaining 25%. The new facility will be built on the JV’s existing site in the Tianjin Economic Development Area. More details....
Help employers find you! Check out all the jobs and post your resume.
